Great Basin Says USPTO Issued U.S. Patent 9200312 for the Company's Compositions for Signal Amplification.

Great Basin Scientific, Inc. GBSN, a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent 9200312 for the Company's compositions for signal amplification. The underlying technology improves assay sensitivity; provides for detection of pathogens directly from clinical specimens such as blood, lung aspirates, urine, stool and swabs at low levels, without the need for time consuming and expensive techniques such as PCR; and can be utilized with all potential diagnostic targets, including nucleic acids and proteins. The patent protects development of highly-sensitive immunoassay-based testing with expanded targets on the Great Basin testing platform. "Great Basin is committed to protecting See full press release